A major challenge in drug discovery and toxicology is the gap between cell-level studies and whole-animal or human systems. Researchers are now creating miniaturized human-on-a-chip systems where human-derived cells connect and function in ways that reflect real tissue and organ behavior, enabling more accurate evaluation of drug efficacy and safety.

In this webinar, James Hickman will discuss developing advanced multi-organ human-on-a-chip systems that model neural, muscle, and cardiac subsystems and how these platforms can inform preclinical decision-making.

Topics to be covered:
• Design, fabrication, and validation of multi-organ human-on-a-chip systems
• Modeling motor, cognitive, muscle, and cardiac functions
• Applications in preclinical drug discovery and toxicity testing
  • 1595863069-9381c1966094975c
    Drug Discovery News Webinars
  • 1765533711-6c5e74cdfdd70494
    James Hickman, Ph.D.
    Professor, University of Central Florida
    James Hickman is the Founding Director of the NanoScience Technology Center at the University of Central Florida and a professor across multiple scientific disciplines. His three decades of work focus on bioelectronics, hybrid biosensor systems, and advanced human body-on-a-chip models, leading to major contributions in defined in vitro systems and multi-organ toxicity studies. He has published extensively, holds numerous patents, cofounded the biotechnology company Hesperos, and is recognized as a Fellow of AIMBE and AVS.